Dachaigh › Lymphoma Burkitt › Massachusetts › Boston
Sgrùdaidhean clionaigeach Lymphoma Burkitt ann an Boston, MA
Tha 10 sgrùdaidhean airson Lymphoma Burkitt a’ lorg phàirtichean aig làraichean ann agus timcheall air Boston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 2
- Dana-Farber Cancer Institute, Boston
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
A’ fastadhÌre 3
- Dana-Farber Cancer Institute, Boston
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A’ fastadhÌre 2
- Dana-Farber Cancer Institute, Boston
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
A’ fastadhÌre 1/2
- Dana-Farber Cancer Institute ( Site 1013), Boston
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 1
- Tufts Medical Center, Boston
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A’ fastadhÌre 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Study of SGR-1505 in Mature B-Cell Neoplasms
A’ fastadhÌre 1
- Beth Israel Deaconess Medical Center, Boston
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
A’ fastadhÌre 1
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
A’ fastadhÌre 1/2
- Dana Farber Cancer Institute, Boston
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
A’ fastadhÌre 2
- Floating Hospital for Children at Tufts Medical Center, Boston
- Dana Faber Cancer Institute/ Boston Children's Hospital, Boston
Sgrùdaidhean Lymphoma Burkitt ann am bailtean eile
- Houston, TX21 sgrùdaidhean
- Milwaukee, WI16 sgrùdaidhean
- Philadelphia, PA16 sgrùdaidhean
- New York City, NY14 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Cincinnati, OH12 sgrùdaidhean
- Atlanta, GA12 sgrùdaidhean
- Seattle, WA11 sgrùdadh
- Durham, NC10 sgrùdaidhean
- Aurora, CO10 sgrùdaidhean
- Los Angeles, CA10 sgrùdaidhean
- Kansas City, MO10 sgrùdaidhean
Sgrùdaidhean eile ann an Boston
- Aillse a' bhroilleach111 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag90 sgrùdaidhean
- Aillse (gach seòrsa)86 sgrùdaidhean
- Aillse colorectal63 sgrùdaidhean
- Ailse metastatach63 sgrùdaidhean
- Ailseachadh nan Sgamhan62 sgrùdaidhean
- Cancer Ovarian61 sgrùdaidhean
- Aillse Prostata59 sgrùdaidhean
- Depression52 sgrùdaidhean
- Ailse Endometrial50 sgrùdaidhean
- Fàilligeadh a' Chridhe44 sgrùdaidhean
- Leukemia myeloid geur44 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.